Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome
Piero Ruscitti, Paola Cipriani, Paola Di Benedetto, et al.
Clinical & Experimental Immunology (2017) Vol. 191, Iss. 2, pp. 220-228
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

A comprehensive review on adult onset Still's disease
Roberto Giacomelli, Piero Ruscitti, Yehuda Shoenfeld
Journal of Autoimmunity (2018) Vol. 93, pp. 24-36
Closed Access | Times Cited: 345
Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 278
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
Carlo Perricone, Elena Bartoloni, Roberto Bursi, et al.
Immunologic Research (2020) Vol. 68, Iss. 4, pp. 213-224
Open Access | Times Cited: 203
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 30
Emerging and Dynamic Biomedical Uses of Ferritin
Brian Chiou, James R. Connor
Pharmaceuticals (2018) Vol. 11, Iss. 4, pp. 124-124
Open Access | Times Cited: 99
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
Piero Ruscitti, Onorina Berardicurti, Paola Di Benedetto, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 95
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, et al.
Cytokine (2021) Vol. 144, pp. 155593-155593
Open Access | Times Cited: 86
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
Piero Ruscitti, Paola Di Benedetto, Onorina Berardicurti, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?
Piero Ruscitti, Onorina Berardicurti, Antonio Barile, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 11, pp. 1515-1516
Closed Access | Times Cited: 47
Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
Piero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
Paola Di Benedetto, Paola Cipriani, Daniela Iacono, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0235326-e0235326
Open Access | Times Cited: 43
Criteria and potential predictors of severity in patients with COVID-19
Niveen E. Zayed, Ahmad Abbas, Samah Lutfy
Egyptian Journal of Bronchology (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 23
Modulation of Iron Metabolism in Response to Infection: Twists for All Tastes
Ana Cordeiro Gomes, Ana C. Moreira, Gonçalo Mesquita, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 3, pp. 84-84
Open Access | Times Cited: 44
Pathogenesis of adult onset still’s disease: current understanding and new insights
Piero Ruscitti, Roberto Giacomelli
Expert Review of Clinical Immunology (2018) Vol. 14, Iss. 11, pp. 965-976
Closed Access | Times Cited: 44
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
Piero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
Medicine (2019) Vol. 98, Iss. 15, pp. e15123-e15123
Open Access | Times Cited: 39
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still’s disease
Piero Ruscitti, Francesco Ursini, Onorina Berardicurti, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 1, pp. 321-329
Closed Access | Times Cited: 21
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications
Piero Ruscitti, Ilenia Di Cola, Claudia Di Muzio, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 7, pp. 103114-103114
Closed Access | Times Cited: 20
Activation mechanisms of monocytes/macrophages in adult-onset Still disease
Hiroto Tsuboi, Seiji Segawa, Mizuki Yagishita, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Eppur Si Muove: ferritin is essential in modulating inflammation
Κassem Sharif, Vânia Vieira Borba, Gisele Zandman‐Goddard, et al.
Clinical & Experimental Immunology (2017) Vol. 191, Iss. 2, pp. 149-150
Open Access | Times Cited: 32
Gastrointestinal microbiota: A predictor of COVID-19 severity?
Maria Adriana Neag, Damiana-Maria Vulturar, Diana Gherman, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 45, pp. 6328-6344
Open Access | Times Cited: 15
Hyperferritinaemia: An Iron Sword of Autoimmunity
Joanna Giemza-Stokłosa, Md Asiful Islam, Przemysław Kotyla
Current Pharmaceutical Design (2019) Vol. 25, Iss. 27, pp. 2909-2918
Closed Access | Times Cited: 25
Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd
Fatemeh Sadeghi-Nodoushan, Mohamad Reza Zare‐Khormizi, Seyedhossein Hekmatimoghaddam, et al.
International Journal of Clinical Practice (2024) Vol. 2024, pp. 1-13
Open Access | Times Cited: 2
Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis
Silvia Rosina, Valentina Natoli, Stefania Santaniello, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 8, pp. 853-870
Closed Access | Times Cited: 14
The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients
Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli, et al.
Seminars in Immunology (2021) Vol. 58, pp. 101632-101632
Closed Access | Times Cited: 14
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile
Piero Ruscitti, Anna Maria Barile, Onorina Berardicurti, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top